Description
A modulator of P-gp (Ki = 59 nM); restores the sensitivity of P-gp-expressing cancer cells to vinblastine, doxorubicin, etoposide, and paclitaxel; enhances the distribution of P-gp substrates through the BBB into the brain
Formal name: (αR)-4-[(1aα,6α,10bα)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-1-piperazineethanol, trihydrochloride
Synonyms: LY335979|RS 33295-198
Molecular weight: 637
CAS: 167465-36-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Cytochrome P450||Product Type|Biochemicals|Transporter & Exchanger Modulators||Research Area|Cancer|Multidrug Resistance